AIHC Capital Management Ltd Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0002103725

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q2 2026 Q1 2026 Q4 2025

Q2 2026 · 4 positions · Total reported value $104.24M · Top-10 concentration 100.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 40.0% · 0 new · 1 cut · 1 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, AIHC Capital Management Ltd disclosed 4 equity positions with a combined reported value of $104.24M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were RVMD ($56.77M), ORIC ($41.46M), NBP ($5.61M). By sector, the heaviest allocations are Health Care 100.0%.

Versus the prior quarter, AIHC Capital Management Ltd opened 0 new positions, trimmed 1 and fully exited 1, a turnover rate of 40.0% of positions. The portfolio's overlap with the prior quarter was 80% of names.

Of the 1 positions fully exited versus the prior quarter, the largest were COGT ($1.98M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

No new positions this quarter.

Fully Exited (vs previous quarter)

  • COGT COGENT BIOSCIENCES INC · prev qtr: $1.98M

Insider Transactions (Form 4)

Latest AIHC Capital Management Ltd buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

AIHC Capital Management Ltd is an SEC-registered 13F filer. As of Q2 2026 it reported 4 US equity positions with a combined value of $104.24M. HoldingsHub carries 3 quarters of its filings (Q4 2025–Q2 2026).

Portfolio Structure

  • 4 positions · $104.24M reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 54.5%
  • Average position size: $26.06M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 2 added, 1 reduced, 1 exited
  • 1 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund appears to be shifting its focus towards more speculative and potentially high-growth healthcare companies, with a significant increase in positions in ORIC and NBP. This could indicate a bullish outlook on the healthcare sector, particularly biotech and pharmaceuticals, or a desire to capitalize on emerging trends. 2. Key Moves: - Added: ORIC (ORIC PHARMACEUTICALS INC) by 55.7% and NBP (NOVABRIDGE BIOSCIENCES) by 27.2%. - Reduced: RVMD (REVOLUTION MEDICINES INC) by 63.4%. - No new positions were added. 3. Portfolio Structure: - Passive/Active: The rebalancing seems active, as the fund is making significant changes to its holdings. - Sector Bias: The portfolio has a strong bias towards healthcare, particularly biotech and pharmaceuticals. - Risk Appetite: The fund is taking on a higher risk appetite with a significant increase in speculative holdings like ORIC and NBP. 4. Per-Holding One-Liner: - RVMD: Revolution Medicines Inc. is focused on developing novel cancer therapies. (unverified) - ORIC: Oric Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for cancer. (unverified) - NBP: Novabridge Biosciences is a biotechnology company developing novel therapies for neurological disorders. (unverified) - KRRO: Korro Bio Inc. is a biotechnology company focused on developing treatments for rare and orphan diseases. (unverified) 5. One-Sentence Style Summary: AIHC Capital Management Ltd's rebalancing in Q2 2026 reflects a strategic shift towards high-growth healthcare stocks, with a focus on biotech and pharmaceuticals, indicating a proactive approach to capitalizing on sector trends and emerging companies.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 100.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 303.13K $56.77M 54.46%
54.46%
Reduce
2 3.83M $41.46M 39.77%
39.77%
Add
3 2.88M $5.61M 5.38%
5.38%
Add
4 30.27K $398.89K 0.38%
0.38%
Hold

FAQ

What did AIHC Capital Management Ltd buy in 2026-Q2?

In its 2026-Q2 13F filing, AIHC Capital Management Ltd reported 4 equity positions worth $104.24M in aggregate; its largest disclosed positions were RVMD ($56.77M), ORIC ($41.46M), NBP ($5.61M).

How large is AIHC Capital Management Ltd's portfolio?

AIHC Capital Management Ltd reported $104.24M of long equity holdings across 4 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.

What is AIHC Capital Management Ltd's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/aihc-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →